International Biotechnology Trust plc
IBT.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$333.93M
Close$
Share Statistics
| Market cap | $333.93 Million |
|---|---|
| Enterprise Value | $360.71 Million |
| Dividend Yield | $31.31 (2.98%) |
| Earnings per Share | $-0.03 |
| Beta | 0.47 |
| Outstanding Shares | 32,309,921 |
Return
| Return on Equity | 30.06% |
|---|---|
| Return on Assets | 27.30% |
| Return on Invested Capital | 30.36% |
Valuation & Multiples
| P/E Ratio | 4.36 |
|---|---|
| PEG | 0.39 |
| Price to Sales | 350.0 |
| Price to Book Ratio | 116.67 |
| Enterprise Value to Revenue | 3.08 |
| Enterprise Value to EBIT | 3.74 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About International Biotechnology Trust plc
0
CEO: Catherine Elizabeth Bingham International Biotechnology Trust plc focuses its capital allocation primarily on companies in their development and late-stage phases. A substantial portion of its assets is dedicated to publicly traded small and mid-capitalization ente...